查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1870606

生物可吸收植入市場按材料類型、應用、產品類型和最終用戶分類 - 全球預測 2025-2032

Bioresorbable Implants Market by Material Type, Application, Product Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物可吸收植入市場將成長至 100.7 億美元，複合年成長率為 7.41%。

關鍵市場統計數據
基準年 2024 56.8億美元
預計年份：2025年 60.9億美元
預測年份 2032 100.7億美元
複合年成長率 (%) 7.41%

生物可吸收植入代表了醫療設備設計的模式轉移。這些材料旨在發揮治療功能，其設計目的是在完成治療後安全分解並被人體吸收。這些技術融合了材料科學、聚合物化學和器械工程，可提供臨時結構支撐、局部藥物傳輸或促進組織再生的生物活性支架。隨著臨床越來越重視最大限度減少異物長期留存的解決方案，生物可吸收植入在多個專科領域取得了進展，從介入心臟病學到整形外科重組和眼科藥物輸送。

臨床醫生和醫療器材研發人員正就一種實證方法達成共識，將分解動力學與生物癒合時間線相匹配。可吸收技術的監管途徑已日趨成熟，生產和滅菌製程也已最佳化，以維持材料的完整性和臨床性能。同時，聚合物化學家、生物醫學工程師和外科醫生之間的多學科合作正在加速推進，設計迭代正在進行中，旨在確保治療期間的耐久性和治療後可預測的吸收。

從概念到臨床應用，不僅需要令人信服的臨床結果，還需要可重複的生產流程、可擴展的供應鏈以及明確的報銷標準。當相關人員評估各種機會時，臨床需求、材料特性和商業化準備之間的策略性相互作用，將決定哪些可吸收解決方案能夠從研究階段走向臨床應用。本報告對這些因素進行了深入而全面的分析，旨在為策略規劃和投資決策提供參考。

新興的科學、臨床和製造趨勢正在迅速改變生物可吸收植入植入方案的開發和應用。

隨著技術進步和臨床需求的融合，生物可吸收植入的模式正在重塑，其設計、測試和應用方式也隨之改變。聚合物化學的創新催生了諸如具有可調分解速率和機械性能的脂肪族聚酯等材料，使植入物能夠更精準地匹配組織癒合的時間線。積層製造和微加工技術實現了複雜的幾何形狀和孔隙率梯度，從而能夠控制吸收動力學並增強組織整合。這些進步正在轉化為新一代植入，它們功能強大，同時在關鍵的恢復階段中具有臨時性。

近期關稅政策變化如何影響生物可吸收植入製造商的供應鏈韌性、籌資策略和商業計劃

關鍵市場關稅政策的變化可能對生物可吸收植入製造商的供應鏈、籌資策略和商業計劃產生重大影響。隨著2025年關稅調整的實施，醫療設備供應商和零件製造商正在重新審視其全球採購結構，以降低成本波動，並確保關鍵原料和成品的穩定供應。在進口聚合物、基材和滅菌服務關稅推高到岸成本的地區，企業正在考慮採取近岸外包、供應商多元化和垂直整合等策略性應變措施。

結合材料科學、臨床應用、產品類型和終端用戶趨勢的詳細細分分析，指導產品開發和商業化選擇。

關鍵細分市場分析揭示了重要的技術和商業性差異，這些差異決定了產品的適用性、臨床應用性和研發重點。材料選擇仍然至關重要；聚己內酯、Polyglycolic乙醇酸、聚乳酸和聚乳酸-羥基乙酸共聚物各自具有不同的分解特性、機械性能和加工要求，這些都會影響器械的設計選擇和臨床適應症。設計人員必須選擇合適的聚合物，以配合所需的吸收時間和宿主組織反應，確保在所需的治療週期中保持結構完整性。

比較區​​域趨勢如何影響主要全球市場的監管路徑、臨床應用模式和生產重點

區域趨勢對臨床應用、監管路徑和生產投資有顯著影響，從而為每個主要區域創造了獨特的策略要務。美洲地區臨床試驗活動高度集中，心血管和整形外科等專科手術量龐大，並有完善的健保報銷體系。這可能加速療效已獲驗證的醫療器材進入市場。國內供應鏈的考量和政策轉變也在推動本地製造能力的提升，以降低跨境中斷和關稅影響的風險。

生物可吸收植入領域領導者的競爭優勢和組織要求包括卓越的製造流程、監管策略和臨床證據產生。

生物可吸收植入領域由成熟的醫療設備製造商、專業聚合物開發商和專注於特定臨床應用的靈活新興企業組成。產業領導者憑藉其整合材料化學、器材設計和臨床證據生成的能力脫穎而出，而新興企業傾向於憑藉新型材料、創新製造方法或具有顯著未滿足需求的特定臨床領域競爭。隨著大型公司利用新型可吸收技術強化其產品組合，以及小型創新者尋求更廣泛的市場進入，策略聯盟和授權協議十分常見。

製造商可採取的策略重點是協調材料創新、可擴展製造和臨床證據生成，以加速材料應用。

為了將技術潛力轉化為永續的商業性成功，產業領導者應採取協作策略，整合材料創新、臨床檢驗和供應鏈韌性。首先，應優先考慮具有可調分解特性和可預測機械性能的材料組合，並投資於將聚合物性能與臨床癒合時間聯繫起來的轉化研究。能夠預測生物反應和分解產物的可靠臨床前項目可以降低監管風險，並增強臨床醫生的信心。

採用透明、多方面的研究途徑，結合專家訪談、技術資料分析、法規審查、競爭和供應鏈評估。

本研究結合了對臨床專家、材料科學家、醫療設備工程師和採購人員的訪談，並嚴格審查了監管文件、公開臨床試驗註冊資訊和同行評審文獻，從而構建了生物可吸收植入的全貌。在調查方法，本研究著重於將定性專家見解與聚合物性能、分解速率和醫療設備動態的技術分析相結合，以確保商業性應用基於材料科學和臨床實際情況。

臨床、生產和經濟因素的綜合考量將決定生物可吸收植入創新能否取得持續的臨床和商業性成功。

生物可吸收植入處於材料科學、臨床需求和衛生經濟學的策略性交匯點，為改善病患預後並減輕長期醫療設備負擔提供了一條途徑。這些醫療設備的未來取決於研發人員如何有效地將聚合物科學轉化為經臨床檢驗的器械，製造商如何確保穩健、高品質的生產能力，以及支付方和醫療服務提供者如何認可並報銷其已展現的價值。那些兼具深厚技術專長、嚴謹的臨床試驗計畫和靈活的供應鏈策略的機構，將最有優勢主導。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將先進聚合物複合材料整合到整形外科植入中，以增強生物吸收控制
  • 用於顱顏重組的患者特異性生物可吸收支架的3D列印
  • 開發用於血管支架中控釋藥物的奈米纖維增強生物可吸收材料
  • 監管協調工作旨在簡化生物可吸收心血管植入的臨床核准
  • 介入性心臟病學的進步推動了微創生物可吸收植入輸送系統的興起。
  • 推出用於即時監測組織癒合和植入劣化的智慧生物可吸收感測器
  • 聚合物化學創新者與醫療設備製造商建立策略聯盟，共同開發下一代植入

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依材料類型分類的生物可吸收植入市場

  • 聚己內酯
  • Polyglycolic
  • 聚乳酸
  • 聚乳酸-羥基乙酸共聚物

第9章 依應用分類的生物可吸收植入市場

  • 心血管系統
    • 修補補丁
    • 支架
      • 血管支架
    • 血管移植物
      • 冠狀動脈移植
      • 周邊移植
  • 牙科
    • 骨移植材料
    • 電影
  • 眼科
    • 藥物輸送
    • 鷹架
    • 縫合線
  • 整形外科
    • 骨再生
      • 接枝
      • 油灰
      • 鷹架
    • 骨折固定
      • 別針
      • 盤子
      • 擰緊
    • 脊椎融合手術
      • 籠
      • 桿
      • 擰緊

第10章 生物可吸收植入市場（依產品類型分類）

  • 藥物輸送系統
    • 水凝膠
    • 微球
  • 固定裝置
    • 別針
    • 盤子
    • 擰緊
  • 鷹架
    • 骨支架
    • 組織支架
  • 縫合線
    • 編織
    • 單絲

第11章 依最終用戶分類的生物可吸收植入市場

  • 門診手術中心
  • 診所
  • 醫院

第12章 生物可吸收植入市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 生物可吸收植入市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國生物可吸收植入市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Johnson & Johnson
    • Medtronic plc
    • Boston Scientific Corporation
    • Abbott Laboratories
    • Stryker Corporation
    • B. Braun Melsungen AG
    • Zimmer Biomet Holdings, Inc.
    • Teleflex Incorporated
    • ConMed Corporation
    • Orthofix Medical Inc.
Product Code: MRR-1A1A064C0211

The Bioresorbable Implants Market is projected to grow by USD 10.07 billion at a CAGR of 7.41% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.68 billion
Estimated Year [2025] USD 6.09 billion
Forecast Year [2032] USD 10.07 billion
CAGR (%) 7.41%

Bioresorbable implants represent a paradigm shift in medical device design, where materials engineered to perform a therapeutic function are designed to safely degrade and be absorbed by the body after serving their purpose. These technologies blend materials science, polymer chemistry, and device engineering to deliver temporary structural support, localized drug delivery, or biologically active scaffolding that promotes native tissue regeneration. As clinical practice increasingly prioritizes solutions that minimize long-term foreign body presence, bioresorbable options are advancing across multiple specialties, from cardiovascular interventions to orthopedic reconstruction and ophthalmic drug delivery.

Clinicians and device developers are converging on an evidence-driven approach that balances the kinetics of degradation with the biological timeline of healing. Regulatory pathways have matured to accommodate resorbable technologies, while manufacturing and sterilization processes have been optimized to maintain material integrity and clinical performance. Concurrently, cross-disciplinary collaborations among polymer chemists, biomedical engineers, and surgeons are accelerating design iterations that address durability during the therapeutic window and predictable absorption thereafter.

Transitioning from concept to clinical adoption requires not only compelling clinical outcomes but also reproducible manufacturing, scalable supply chains, and clear reimbursement narratives. As stakeholders evaluate opportunities, the strategic interplay of clinical need, material properties, and commercialization readiness defines which resorbable solutions will move from investigational use to standard of care. This report offers an incisive synthesis of those forces to inform strategic planning and investment decisions.

Emerging scientific, clinical, and manufacturing dynamics that are rapidly transforming the development and adoption of bioresorbable implant solutions

The bioresorbable implant landscape is being reshaped by converging technological advances and clinical imperatives that are changing how devices are conceived, tested, and adopted. Innovations in polymer chemistry are producing materials such as aliphatic polyesters with tunable degradation rates and mechanical profiles, enabling devices that match tissue healing timelines more precisely. Additive manufacturing and microfabrication techniques now permit complex geometries and porosity gradients that enhance tissue integration while controlling resorption kinetics. Together, these advances enable a new generation of implants that are purposefully transient yet functionally robust during critical phases of recovery.

Clinically, the shift toward minimally invasive procedures and outpatient pathways has elevated demand for implants that reduce long-term complications and secondary interventions. Surgeons increasingly embrace devices that support biological healing without leaving permanent hardware, particularly in patient populations where lifelong implants pose risks or complicate imaging and future interventions. At the same time, regulatory frameworks and clinical trial designs have adapted to address device biodegradation, host response, and long-term safety, which streamlines pathways for well-characterized materials and clearly defined performance endpoints.

Economic and operational transformations are also influential. Contract manufacturing organizations and component suppliers are investing in specialized processing capabilities for bioresorbable polymers, while payers and health systems are evaluating total cost of care benefits associated with reduced revision rates. The net effect is a market environment that rewards integrated approaches combining proven materials, scalable manufacturing, and robust clinical evidence, driving rapid maturation of resorbable implant offerings.

How recent tariff policy changes are reshaping supply chain resilience, sourcing strategies, and commercial planning for bioresorbable implant manufacturers

Tariff policy shifts in major markets have the potential to materially influence supply chains, sourcing strategies, and commercial planning for manufacturers of bioresorbable implants. In the wake of tariff adjustments implemented in 2025, device suppliers and component manufacturers have reassessed global procurement footprints to mitigate cost volatility and maintain continuity of critical raw materials and finished goods. Where tariffs raise landed costs for imported polymers, substrates, or sterilization services, firms have evaluated nearshoring, supplier diversification, and vertical integration as strategic responses.

The practical impact extends beyond unit cost. Increased tariffs can lengthen lead times and complicate inventory strategies, prompting manufacturers to increase safety stocks or qualify alternate materials and suppliers. For technology developers, higher cross-border costs incentivize local production of high-value components and may accelerate investments in domestic processing capacity for polymers such as polylactic acid derivatives. Regulatory approvals and quality control systems must keep pace to ensure that rapid supplier changes do not compromise device performance or traceability.

Payers and providers also respond to tariff-driven price shifts by scrutinizing reimbursement pathways and comparative value. In some cases, clinical adoption timelines have been extended while health systems assess whether higher acquisition costs are offset by reductions in long-term complications or reoperation rates. Ultimately, resilient commercial strategies emphasize supply chain transparency, multiple qualified suppliers across geographies, and adaptive contract terms to absorb policy volatility while protecting access to innovative resorbable therapies.

In-depth segmentation analysis linking material science, clinical application, product typology, and end-user dynamics to inform development and commercialization choices

Key segmentation insights reveal critical technical and commercial differences that determine product fit, clinical applicability, and development priorities. Material selection remains foundational, with polycaprolactone, polyglycolic acid, polylactic acid, and polylactic-co-glycolic acid each offering distinct degradation profiles, mechanical characteristics, and processing requirements that influence device design choices and clinical indications. Designers must align polymer selection with the desired resorption timeline and host tissue response to ensure that structural integrity is retained for the required therapeutic window.

Application-driven segmentation highlights the diversity of clinical use cases. In cardiovascular applications, repair patches, stents, and vascular grafts present unique engineering and regulatory demands, where stents may include vascular scaffolds and grafts span coronary and peripheral indications. Dental applications are oriented around bone grafts and membranes that support dental regeneration and implantology. Ophthalmic needs focus on drug delivery vehicles, scaffolds, and sutures that interface with sensitive ocular tissues and require precise degradation control. Orthopedic applications encompass bone regeneration, fracture fixation, and spine fusion; within these, bone regeneration devices include grafts, putty, and scaffolds while fracture fixation leverages pins, plates, and screws and spine fusion employs cages, rods, and screws. Each application imposes distinct mechanical and biological constraints that guide R&D priorities.

Product-type segmentation further refines market opportunity, differentiating drug delivery systems, fixation devices, scaffolds, and sutures. Drug delivery approaches incorporate hydrogels and microspheres to enable localized therapeutic release, whereas fixation devices rely on pins, plates, and screws designed to carry load then resorb. Scaffolds bifurcate into bone scaffolds and tissue scaffolds that provide structural templates for regeneration. Sutures, whether braided or monofilament, must balance handling characteristics with predictable absorption. End-user segmentation across ambulatory surgical centers, clinics, and hospitals shapes purchasing behaviors, inventory needs, and adoption velocity, as institutional capabilities and procedural volumes influence device selection and implementation strategies.

Comparative regional dynamics shaping regulatory pathways, clinical adoption patterns, and manufacturing priorities across major global markets

Regional dynamics exert strong influence on clinical adoption, regulatory pathways, and manufacturing investments, creating distinct strategic imperatives across major geographies. The Americas exhibit concentrated clinical trial activity and significant procedural volumes in specialties such as cardiovascular and orthopedics, supported by established reimbursement frameworks that can accelerate market entry for devices with demonstrated outcomes. Domestic supply chain considerations and policy shifts also incentivize local manufacturing capabilities to reduce exposure to cross-border disruptions and tariff effects.

Europe, Middle East & Africa present a heterogeneous regulatory and healthcare landscape where device approval processes vary by jurisdiction and health technology assessment plays an outsized role in procurement decisions. Reimbursement pathways can be more conservative in parts of this region, promoting rigorous comparative-effectiveness evidence as a prerequisite for widespread adoption. Meanwhile, pockets of rapid adoption exist where clinicians and health systems prioritize minimally invasive and regenerative solutions, creating targeted opportunities for manufacturers able to navigate regional regulatory complexity and deliver compelling clinical value propositions.

Asia-Pacific is characterized by diverse markets ranging from highly advanced healthcare systems to rapidly developing ones, each with unique demands for affordability, scalability, and clinical outcomes. Manufacturing capacity in this region is expanding, and there is growing local demand for innovative implants that align with population health needs. Collaborations between local clinical centers and global developers are increasingly common, enabling both clinical validation and localized product adaptation to meet regulatory and procedural preferences in the region.

Competitive and organizational imperatives that define industry leaders in bioresorbable implants, including manufacturing excellence, regulatory strategy, and clinical evidence generation

Competitive dynamics in the bioresorbable implant sector are driven by a mix of established medical device manufacturers, specialized polymer developers, and agile startups focused on niche clinical applications. Leaders differentiate through integrated capabilities that span material chemistry, device engineering, and clinical evidence generation, while emerging players often compete on novel materials, innovative manufacturing approaches, or targeted clinical niches where unmet needs remain acute. Strategic partnerships and licensing arrangements are common as larger firms seek to augment portfolios with novel resorbable technologies and smaller innovators pursue broader market access.

Manufacturing competency is a critical competitive axis. Firms that invest in validated polymer processing, sterilization protocols compatible with resorbable substrates, and scalable assembly lines gain time-to-market advantages. Quality systems and regulatory know-how are equally important; companies that streamline submission pathways through robust preclinical characterization and early clinical collaborations can accelerate adoption. Additionally, supply chain resilience-including secured sources for medical-grade polymers and backup suppliers for critical components-constitutes a competitive moat against operational disruptions.

Commercial success also depends on clinical and payer engagement. Organizations that proactively generate real-world evidence, demonstrate reductions in reoperation rates or device-related complications, and articulate clear health-economic value propositions are better positioned to achieve reimbursement and clinician adoption. Finally, service models such as surgeon training, procedural support, and data-driven outcomes tracking can amplify market penetration and create differentiated value for customers.

Actionable strategic priorities for manufacturers to align material innovation, scalable manufacturing, and clinical evidence generation to accelerate adoption

Industry leaders should pursue a coordinated strategy that aligns materials innovation, clinical validation, and supply chain resilience to convert technological promise into sustainable commercial success. First, prioritize material portfolios that offer tunable degradation profiles and predictable mechanical performance, and invest in translational studies that link polymer properties to clinical healing timelines. Robust preclinical programs that anticipate host response and degradation byproducts will reduce regulatory risk and build clinician confidence.

Second, strengthen manufacturing and quality systems to support scale-up and to ensure consistent performance across lots. Qualification of multiple qualified suppliers for critical polymers and components, coupled with strategic nearshoring or regional manufacturing footprints, will reduce exposure to tariff-related cost shifts and shipping disruptions. Parallel investments in sterilization validation and packaging technologies tailored for resorbable substrates will preserve device integrity through the supply chain.

Third, design clinical development and market access plans that emphasize real-world evidence and health-economic outcomes. Align trial endpoints with payer requirements and clinician priorities to accelerate reimbursement conversations. Finally, cultivate collaborative commercialization models that include clinician education, procedure-level support, and outcomes monitoring to demonstrate comparative value. By integrating these strategic pillars-materials, manufacturing, clinical evidence, and commercial enablement-organizations can de-risk innovation pathways and accelerate adoption in diverse care settings.

Transparent multi-method research approach combining expert interviews, technical material analysis, regulatory review, and competitive and supply chain assessments

This research synthesizes primary interviews with clinical experts, material scientists, device engineers, and procurement leaders, combined with a rigorous review of regulatory filings, public clinical trial registries, and peer-reviewed literature to build a comprehensive view of the bioresorbable implant landscape. Methodological emphasis was placed on triangulating qualitative insights from subject-matter experts with technical analyses of polymer performance, degradation kinetics, and device biomechanics, ensuring that commercial implications are rooted in material science and clinical realities.

Analytical frameworks included segmentation mapping by material, application, product type, and end-user to surface differences in clinical requirements and adoption dynamics. Supply chain assessments evaluated manufacturing capacity, critical inputs, and policy exposure, including tariff sensitivities and logistical constraints. Competitive profiling assessed organizational capabilities across R&D, manufacturing, regulatory affairs, and commercialization, while regional analysis considered regulatory heterogeneity, payer environments, and clinical practice patterns.

Limitations are acknowledged: the dynamic nature of regulatory decisions and ongoing clinical research means that guidance is based on the best available evidence at the time of report preparation, and stakeholders should incorporate new clinical data and policy developments into decision models. Where appropriate, the research team employed conservative assumptions regarding adoption timelines and prioritized evidence from clinical studies and validated engineering characterizations rather than uncorroborated claims.

Synthesis of clinical, manufacturing, and economic imperatives that determine which bioresorbable implant innovations will achieve durable clinical and commercial success

Bioresorbable implants occupy a strategic intersection of materials science, clinical need, and healthcare economics, offering pathways to improve patient outcomes while reducing long-term device burden. The trajectory of this class of devices will be determined by how effectively developers translate polymer science into clinically validated devices, how manufacturers secure resilient and high-quality production capabilities, and how payers and providers recognize and reimburse demonstrated value. Those organizations that integrate deep technical expertise with rigorous clinical programs and adaptive supply chain strategies will be best positioned to lead.

As the healthcare ecosystem continues to emphasize value-based care and minimally invasive therapies, demand for resorbable solutions that lower reoperation rates and simplify patient management is likely to grow. However, realizing that potential requires coordinated investment in material optimization, regulatory preparedness, and real-world outcomes generation. Stakeholders who move decisively to align these elements will not only unlock clinical benefits but also capture commercial advantage in a landscape where predictability of performance and evidence of value are paramount.

In sum, bioresorbable implants present compelling opportunities for innovation-driven growth, yet success depends on disciplined execution across science, manufacturing, and clinical validation. Organizations that adopt an integrated approach will shape the next wave of resorbable therapies and set new standards for patient-centered device design.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of advanced polymer composites for enhanced bioresorption control in orthopedic implants
  • 5.2. Adoption of 3D printed patient-specific bioresorbable scaffolds for craniofacial reconstruction
  • 5.3. Development of nanofiber reinforced bioresorbable materials for controlled drug delivery in vascular stents
  • 5.4. Regulatory harmonization efforts for streamlining clinical approval of bioresorbable cardiovascular implants
  • 5.5. Rise in minimally invasive delivery systems for bioresorbable implants driven by interventional cardiology advancements
  • 5.6. Implementation of smart bioresorbable sensors for real-time monitoring of tissue healing and implant degradation
  • 5.7. Strategic collaborations between polymer chemistry innovators and medical device firms for next-generation implants

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bioresorbable Implants Market, by Material Type

  • 8.1. Polycaprolactone
  • 8.2. Polyglycolic Acid
  • 8.3. Polylactic Acid
  • 8.4. Polylactic-Co-Glycolic Acid

9. Bioresorbable Implants Market, by Application

  • 9.1. Cardiovascular
    • 9.1.1. Repair Patches
    • 9.1.2. Stents
      • 9.1.2.1. Vascular Scaffold
    • 9.1.3. Vascular Grafts
      • 9.1.3.1. Coronary Grafts
      • 9.1.3.2. Peripheral Grafts
  • 9.2. Dental
    • 9.2.1. Bone Grafts
    • 9.2.2. Membranes
  • 9.3. Ophthalmic
    • 9.3.1. Drug Delivery
    • 9.3.2. Scaffolds
    • 9.3.3. Sutures
  • 9.4. Orthopedic
    • 9.4.1. Bone Regeneration
      • 9.4.1.1. Grafts
      • 9.4.1.2. Putty
      • 9.4.1.3. Scaffolds
    • 9.4.2. Fracture Fixation
      • 9.4.2.1. Pins
      • 9.4.2.2. Plates
      • 9.4.2.3. Screws
    • 9.4.3. Spine Fusion
      • 9.4.3.1. Cages
      • 9.4.3.2. Rods
      • 9.4.3.3. Screws

10. Bioresorbable Implants Market, by Product Type

  • 10.1. Drug Delivery Systems
    • 10.1.1. Hydrogels
    • 10.1.2. Microspheres
  • 10.2. Fixation Devices
    • 10.2.1. Pins
    • 10.2.2. Plates
    • 10.2.3. Screws
  • 10.3. Scaffolds
    • 10.3.1. Bone Scaffolds
    • 10.3.2. Tissue Scaffolds
  • 10.4. Sutures
    • 10.4.1. Braided
    • 10.4.2. Monofilament

11. Bioresorbable Implants Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Hospitals

12. Bioresorbable Implants Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Bioresorbable Implants Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Bioresorbable Implants Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Johnson & Johnson
    • 15.3.2. Medtronic plc
    • 15.3.3. Boston Scientific Corporation
    • 15.3.4. Abbott Laboratories
    • 15.3.5. Stryker Corporation
    • 15.3.6. B. Braun Melsungen AG
    • 15.3.7. Zimmer Biomet Holdings, Inc.
    • 15.3.8. Teleflex Incorporated
    • 15.3.9. ConMed Corporation
    • 15.3.10. Orthofix Medical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS BIORESORBABLE IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BIORESORBABLE IMPLANTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. BIORESORBABLE IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIORESORBABLE IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYCAPROLACTONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY POLYLACTIC-CO-GLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY REPAIR PATCHES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR SCAFFOLD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CORONARY GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PERIPHERAL GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DENTAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MEMBRANES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY OPHTHALMIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE REGENERATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY GRAFTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PUTTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SPINE FUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CAGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY RODS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HYDROGELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY FIXATION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY PLATES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCREWS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BONE SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY TISSUE SCAFFOLDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY BRAIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY MONOFILAMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL BIORESORBABLE IMPLANTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)

TABLE